Clinical Trials Browser

INDUSTRY × Chordoma × spartalizumab × Clear all

NCT02936102 2025-11-14

A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.

Phase 1 Terminated

Chordoma, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms